TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Boston Scientific Acurate neo2 TAVR

ACURATE neo2 valve linked to successful commissural alignment during TAVR

The new Boston Scientific valve received CE mark approval in 2020, but has not been approved by the FDA.

Medtronic launches Evolut FX TAVR system aortic stenosis

New feature found on Evolut FX valve helps cardiologists confirm commissural alignment during TAVR

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies. 

Medicare money payment physician

TAVR costs vary significantly from one hospital to the next

According to a new study of more than 119,000 hospitalizations, the costs associated with TAVR are far from consistent. 

The SAPIEN 3 Ultra (S3U) transcatheter heart valve from Edwards Lifesciences is

Next-generation TAVR valve delivers strong outcomes, reduced PVL after one year

A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.

Nurse checking in patient

Structural heart clinics see key benefits from improved referral tracking

Sponsored by Medtronic

Identifying patients with severe aortic stenosis who could potentially benefit from transcatheter aortic valve replacement (TAVR) is very important—but managing and tracking them over time can be quite a challenge.

Doctor at computer

Data mining helps hospitals identify new patients in need of TAVR, other structural heart procedures

Sponsored by Medtronic

When the ACC and AHA collaborated on new valvular heart disease guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as TAVR. However, an estimated one-third of patients with severe aortic stenosis in the U.S. still lack a guideline-recommended treatment plan.

Thumbnail

What new data tell us about TAVR in women with a history of early menopause

Researchers examined data from more than 700 TAVR patients, publishing their findings in the American Journal of Cardiology.

ACC 2023 ACC.23 American College of Cardiology

Day 2 at ACC.23 features late-breaking studies on TEER, TAVR, EHR alerts and much more

Catch up on the biggest news that came out of the second day of ACC.23 in New Orleans. 

Displaying 193 - 200 of 417

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.